AU2016900527A0 - Formulation and method of use - Google Patents

Formulation and method of use

Info

Publication number
AU2016900527A0
AU2016900527A0 AU2016900527A AU2016900527A AU2016900527A0 AU 2016900527 A0 AU2016900527 A0 AU 2016900527A0 AU 2016900527 A AU2016900527 A AU 2016900527A AU 2016900527 A AU2016900527 A AU 2016900527A AU 2016900527 A0 AU2016900527 A0 AU 2016900527A0
Authority
AU
Australia
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016900527A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ATP INSTITUTE Pty Ltd
Original Assignee
ATP INSTITUTE Pty Ltd
Filing date
Publication date
Application filed by ATP INSTITUTE Pty Ltd filed Critical ATP INSTITUTE Pty Ltd
Publication of AU2016900527A0 publication Critical patent/AU2016900527A0/en
Priority to EP17752571.4A priority Critical patent/EP3416665A4/en
Priority to AU2017220388A priority patent/AU2017220388A1/en
Priority to CN201780010424.8A priority patent/CN108601807A/en
Priority to US15/998,840 priority patent/US20190328013A1/en
Priority to PCT/AU2017/050136 priority patent/WO2017139846A1/en
Priority to CA3013835A priority patent/CA3013835A1/en
Abandoned legal-status Critical Current

Links

AU2016900527A 2016-02-16 2016-02-16 Formulation and method of use Abandoned AU2016900527A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP17752571.4A EP3416665A4 (en) 2016-02-16 2017-02-16 Formulation and method of use
AU2017220388A AU2017220388A1 (en) 2016-02-16 2017-02-16 Formulation and method of use
CN201780010424.8A CN108601807A (en) 2016-02-16 2017-02-16 Preparation and application method
US15/998,840 US20190328013A1 (en) 2016-02-16 2017-02-16 Formulation and Method of Use
PCT/AU2017/050136 WO2017139846A1 (en) 2016-02-16 2017-02-16 Formulation and method of use
CA3013835A CA3013835A1 (en) 2016-02-16 2017-02-16 Formulation and method of use

Publications (1)

Publication Number Publication Date
AU2016900527A0 true AU2016900527A0 (en) 2016-02-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP3429635A4 (en) Anti-crispr compounds and methods of use
EP3504213A4 (en) Amino-pyrrolopyrimidinone compounds and methods of use thereof
EP3402549A4 (en) Microneedle compositions and methods of using same
EP3429591A4 (en) Substituted inhibitors of menin-mll and methods of use
EP3416634A4 (en) Immunomodulatory agents and methods of use thereof
EP3548033A4 (en) Compounds and their methods of use
EP3510040A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3245291A4 (en) Novel micro-dystrophins and related methods of use
EP3377070A4 (en) Compounds and methods of their use
EP3589319A4 (en) Glycan-interacting compounds and methods of use
EP3558998A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3435956A4 (en) Photo-stabilized compositions and methods of use
EP3551033A4 (en) Endoscope and method of use
EP3373969A4 (en) Glycan-interacting compounds and methods of use
EP3495354A4 (en) Ido1 inhibitor and preparation method and application thereof
EP3558475A4 (en) Seated treadmill and method of use
EP3551209A4 (en) Insulin-fc fusions and methods of use
EP3310374A4 (en) Glutathione formulation and method of use
EP3455322A4 (en) Hydrofluoroolefins and methods of using same
EP3416665A4 (en) Formulation and method of use
EP3749343A4 (en) Formulation and method of use
EP3373910A4 (en) Echinomycin formulation, method of making and method of use thereof
EP3341017A4 (en) Immunomodulatory compositions and methods of use thereof
EP3541847A4 (en) Glycan-interacting compounds and methods of use
EP3496804A4 (en) Bioelectric devices and methods of use